TransEnterix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch TransEnterix and buy or sell other stocks, ETFs, and their options commission-free!

About TRXC

Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, and economic shortcomings in surgery. 

CEO
Anthony Fernando, MBA
CEOAnthony Fernando, MBA
Employees
197
Employees197
Headquarters
Durham, North Carolina
HeadquartersDurham, North Carolina
Founded
1988
Founded1988
Employees
197
Employees197

TRXC Key Statistics

Market cap
976.51M
Market cap976.51M
Price-Earnings ratio
-1.56
Price-Earnings ratio-1.56
Dividend yield
Dividend yield
Average volume
718.21K
Average volume718.21K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$1.18
52 Week high$1.18
52 Week low
$0.28
52 Week low$0.28

Stock Snapshot

As of today, TransEnterix(TRXC) shares are valued at $4.08. The company's market cap stands at 976.51M, with a P/E ratio of -1.56.

During the trading day, TransEnterix(TRXC) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 718.21K.

The stock's 52-week range extends from a low of $0.28 to a high of $1.18.

The stock's 52-week range extends from a low of $0.28 to a high of $1.18.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.